ArticleFrontiers in microbiology2018
ESBL-Producing
Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Associations of Biofilm Capacity with Antimicrobial Resistance and Virulence Genes inAntibiotics (Basel, Switzerland) · 2026Article
- Article
- Detection and Characterization of ESBL-Producing and Carbapenem-Resistant Klebsiella pneumoniae in Ornamental Birds and Their Surrounding Environments.MicrobiologyOpen · 2026Article
- Draft genome sequences of three multidrug-resistantMicrobiology resource announcements · 2026Article
- Antimicrobial Resistance in SelectedAntibiotics (Basel, Switzerland) · 2025Review
- Emerging biofilm formation and disinfectant susceptibility of ESBL-producing Klebsiella pneumoniae.Scientific reports · 2025Article
- Detection of virulent Klebsiella pneumoniae strains causing intestinal and extraintestinal infections during the 80s and 90s in Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024Article
- DecodingFrontiers in microbiology · 2024Article
- From Farm to Fork: Persistence of Clinically Relevant Multidrug-Resistant and Copper-Tolerant Klebsiella pneumoniae Long after Colistin Withdrawal in Poultry Production.Microbiology spectrum · 2023Article
- A review of the predictors of antimicrobial use and resistance in European food animal production.Frontiers in antibiotics · 2023Review
- Identification and Antimicrobial Resistance inAnimals : an open access journal from MDPI · 2022Article
- Risk Factors for Persistent Infection of Non-Typhoidal Salmonella in Poultry Farms, North Central Nigeria.Antibiotics (Basel, Switzerland) · 2022Article
- The diversity in antimicrobial resistance of MDRFrontiers in microbiology · 2022Article
- Emergence of Colistin and Carbapenem Resistance in Extended-Spectrum β-Lactamase ProducingBiology · 2021Article
- Epidemiological Dynamics of Extended-SpectrumScientifica · 2021Article
- Occurrence and Molecular Characteristics of Extended-Spectrum Beta-Lactamase-Producing Enterobacterales Recovered From Chicken, Chicken Meat, and Human Infections in Sao Paulo State, Brazil.Frontiers in microbiology · 2021Article
- ESKAPE Bacteria and Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolated from Wastewater and Process Water from German Poultry Slaughterhouses.Applied and environmental microbiology · 2020Article
- Comparison of core-genome MLST, coreSNP and PFGE methods forMicrobial genomics · 2020Article
- Prevalence of Carbapenem-ResistantFrontiers in cellular and infection microbiology · 2020Article
- Antibiotic Administration Routes and Oral Exposure to Antibiotic Resistant Bacteria as Key Drivers for Gut Microbiota Disruption and Resistome in Poultry.Frontiers in microbiology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ESBL-producing
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.